» Articles » PMID: 33281616

Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis-Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain Synthetases

Overview
Journal Front Physiol
Date 2020 Dec 7
PMID 33281616
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Acetate is a major end product of bacterial fermentation of fiber in the gut. Acetate, whether derived from the diet or from fermentation in the colon, has been implicated in a range of health benefits. Acetate is also generated in and released from various tissues including the intestine and liver, and is generated within all cells by deacetylation reactions. To be utilized, all acetate, regardless of the source, must be converted to acetyl coenzyme A (acetyl-CoA), which is carried out by enzymes known as acyl-CoA short-chain synthetases. Acyl-CoA short-chain synthetase-2 (ACSS2) is present in the cytosol and nuclei of many cell types, whereas ACSS1 is mitochondrial, with greatest expression in heart, skeletal muscle, and brown adipose tissue. In addition to acting to redistribute carbon systemically like a ketone body, acetate is becoming recognized as a cellular regulatory molecule with diverse functions beyond the formation of acetyl-CoA for energy derivation and lipogenesis. Acetate acts, in part, as a metabolic sensor linking nutrient balance and cellular stress responses with gene transcription and the regulation of protein function. ACSS2 is an important task-switching component of this sensory system wherein nutrient deprivation, hypoxia and other stressors shift ACSS2 from a lipogenic role in the cytoplasm to a regulatory role in the cell nucleus. Protein acetylation is a critical post-translational modification involved in regulating cell behavior, and alterations in protein acetylation status have been linked to multiple disease states, including cancer. Improving our fundamental understanding of the "acetylome" and how acetate is generated and utilized at the subcellular level in different cell types will provide much needed insight into normal and neoplastic cellular metabolism and the epigenetic regulation of phenotypic expression under different physiological stressors. This article is Part 1 of 2 - for Part 2 see doi: 10.3389/fphys.2020.580171.

Citing Articles

Reprogramming aerobic metabolism mitigates Streptococcus pyogenes tissue damage in a mouse necrotizing skin infection model.

Xu W, Bradstreet T, Zou Z, Hickerson S, Zhou Y, He H Nat Commun. 2025; 16(1):2559.

PMID: 40089471 DOI: 10.1038/s41467-025-57348-x.


Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways.

Kaszycki J, Kim M Front Immunol. 2025; 16:1529756.

PMID: 40046056 PMC: 11879833. DOI: 10.3389/fimmu.2025.1529756.


ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target.

El-Kurjieh A, Al-Arab R, Hachem Q, Ibrahim J, Kobeissy P Lipids Health Dis. 2025; 24(1):74.

PMID: 40001058 PMC: 11853604. DOI: 10.1186/s12944-025-02491-z.


Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease.

Lumpuy-Castillo J, Ruperez F, Porto B, Cristobal C, Tarin N, Huelmos A Biomolecules. 2025; 15(1).

PMID: 39858422 PMC: 11764408. DOI: 10.3390/biom15010027.


Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls.

Tan B, Cheng Y, Li J, Zheng Y, Xiao C, Guo H Aging Clin Exp Res. 2025; 37(1):28.

PMID: 39833609 PMC: 11746959. DOI: 10.1007/s40520-024-02923-3.


References
1.
Engelke U, Liebrand-van Sambeek M, de Jong J, Leroy J, Morava E, Smeitink J . N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem. 2003; 50(1):58-66. DOI: 10.1373/clinchem.2003.020214. View

2.
Sakakibara I, Fujino T, Ishii M, Tanaka T, Shimosawa T, Miura S . Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. Cell Metab. 2009; 9(2):191-202. DOI: 10.1016/j.cmet.2008.12.008. View

3.
Tillander V, Alexson S, Cohen D . Deactivating Fatty Acids: Acyl-CoA Thioesterase-Mediated Control of Lipid Metabolism. Trends Endocrinol Metab. 2017; 28(7):473-484. PMC: 5474144. DOI: 10.1016/j.tem.2017.03.001. View

4.
Lu M, Zhu W, Wang X, Tang J, Zhang K, Yu G . ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition. Cell Metab. 2019; 29(4):886-900.e5. DOI: 10.1016/j.cmet.2018.12.019. View

5.
Urbancikova M . Requirement of amino-terminal modification for striated muscle alpha-tropomyosin function. J Biol Chem. 1994; 269(39):24310-5. View